• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内毒素血症对胰岛素抵抗分子机制的影响。

The influence of endotoxemia on the molecular mechanisms of insulin resistance.

作者信息

Boroni Moreira A P, de Cássia Gonçalves Alfenas R

机构信息

Nutrition Science, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil.

出版信息

Nutr Hosp. 2012 Mar-Apr;27(2):382-90. doi: 10.1590/S0212-16112012000200007.

DOI:10.1590/S0212-16112012000200007
PMID:22732959
Abstract

INTRODUCTION

The reduction in the capacity of insulin to reach its biological effects can lead to a chronic hyperglycemia and hyperinsulinemia, assuming an important role in the pathogenesis of metabolic disorders associated to obesity and diabetes. Insulin resistance is associated to chronic subclinical inflammation, which in part can be mediated by increased plasmatic lipopolysaccharide levels, an endotoxin derived from the membrane of gramnegative bacteria that mainly reside in the gut.

OBJECTIVES

The aim of this review study is to describe the molecular mechanisms involved in the pathogenesis of insulin resistance due to metabolic endotoxemia and of its connection to obesity and diabetes.

RESULTS AND DISCUSSION

Lipopolysaccharide present in the intestinal lumen can reach the circulatory system causing metabolic endotoxemia. When lipopolysaccharide binds to Toll-like receptor 4, inflammation is activated, changing several stages of insulin signaling. It has been shown that chronic exposure to this endotoxin may contribute to weight gain and type 2 diabetes mellitus manifestation. Obese and diabetic people have increased plasmatic lipopolysaccharide levels. The increase in the number of gram-negative bacteria on gut microbiota, the reduction on gut mucosal integrity, and the consumption of high-fat diets increase the plasmatic lipopolysaccharide levels. Therefore, the type of diet consumed may modulate the composition of gut microbiota and improve gut mucosal integrity, decreasing the occurrence of endotoxemia and its postprandial inflammatory effects, leading to adequate insulin signaling. However, there are very few studies that evaluated the influence of nutrients and/or specific food types on metabolic endotoxemia.

摘要

引言

胰岛素发挥生物学效应的能力下降会导致慢性高血糖和高胰岛素血症,在与肥胖和糖尿病相关的代谢紊乱发病机制中起重要作用。胰岛素抵抗与慢性亚临床炎症有关,部分可由血浆脂多糖水平升高介导,脂多糖是一种主要存在于肠道的革兰氏阴性菌细胞膜衍生的内毒素。

目的

本综述研究旨在描述代谢性内毒素血症导致胰岛素抵抗的发病机制及其与肥胖和糖尿病的关联所涉及的分子机制。

结果与讨论

肠腔内存在的脂多糖可进入循环系统,导致代谢性内毒素血症。当脂多糖与Toll样受体4结合时,炎症被激活,改变胰岛素信号传导的多个阶段。研究表明,长期接触这种内毒素可能导致体重增加和2型糖尿病的表现。肥胖和糖尿病患者的血浆脂多糖水平升高。肠道微生物群中革兰氏阴性菌数量增加、肠道黏膜完整性降低以及高脂饮食的摄入都会增加血浆脂多糖水平。因此,所摄入的饮食类型可能会调节肠道微生物群的组成,改善肠道黏膜完整性,减少内毒素血症的发生及其餐后炎症效应,从而使胰岛素信号传导正常。然而,很少有研究评估营养素和/或特定食物类型对代谢性内毒素血症的影响。

相似文献

1
The influence of endotoxemia on the molecular mechanisms of insulin resistance.内毒素血症对胰岛素抵抗分子机制的影响。
Nutr Hosp. 2012 Mar-Apr;27(2):382-90. doi: 10.1590/S0212-16112012000200007.
2
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.肠道微生物群的变化控制高脂饮食诱导的小鼠肥胖和糖尿病中代谢性内毒素血症引发的炎症。
Diabetes. 2008 Jun;57(6):1470-81. doi: 10.2337/db07-1403. Epub 2008 Feb 27.
3
Metabolic endotoxemia initiates obesity and insulin resistance.代谢性内毒素血症引发肥胖和胰岛素抵抗。
Diabetes. 2007 Jul;56(7):1761-72. doi: 10.2337/db06-1491. Epub 2007 Apr 24.
4
Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia.高脂肪饮食对肠道微生物群、肠道通透性和代谢内毒素血症的影响。
Br J Nutr. 2012 Sep;108(5):801-9. doi: 10.1017/S0007114512001213. Epub 2012 Apr 16.
5
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?肠道微生物群与肥胖、胰岛素抵抗和 2 型糖尿病的相互作用:肠道微生物群是否与胰岛素抵抗共同进化?
Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d.
6
The gut microbiota, obesity and insulin resistance.肠道微生物群、肥胖和胰岛素抵抗。
Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16.
7
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.肠道微生物群控制脂肪组织扩张、肠道屏障和葡萄糖代谢:对使用益生元的分子靶点和干预措施的新见解。
Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065.
8
Metabolic endotoxaemia: is it more than just a gut feeling?代谢性内毒素血症:这不仅仅是一种感觉?
Curr Opin Lipidol. 2013 Feb;24(1):78-85. doi: 10.1097/MOL.0b013e32835b4431.
9
Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance.大麻素受体 1 部分介导代谢性内毒素血症引起的炎症和胰岛素抵抗。
Physiol Behav. 2019 Feb 1;199:282-291. doi: 10.1016/j.physbeh.2018.11.035. Epub 2018 Nov 29.
10
Recent advances in the relationship between obesity, inflammation, and insulin resistance.肥胖、炎症与胰岛素抵抗之间关系的最新进展。
Eur Cytokine Netw. 2006 Mar;17(1):4-12.

引用本文的文献

1
Gastrointestinal Permeability After Bariatric Surgery: A Systematic Review.减肥手术后的胃肠道通透性:一项系统评价。
Cureus. 2024 May 17;16(5):e60480. doi: 10.7759/cureus.60480. eCollection 2024 May.
2
Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus.益生元对 2 型糖尿病患者肠道微生物组的有益变化。
Biomolecules. 2023 Aug 25;13(9):1307. doi: 10.3390/biom13091307.
3
Combined Physical Exercise and Diet: Regulation of Gut Microbiota to Prevent and Treat of Metabolic Disease: A Review.
联合体育锻炼和饮食:调节肠道微生物群预防和治疗代谢疾病:综述。
Nutrients. 2022 Nov 11;14(22):4774. doi: 10.3390/nu14224774.
4
Prediction of gestational diabetes mellitus and perinatal outcomes by plasma zonulin levels.血浆亲环素水平预测妊娠期糖尿病及围生期结局。
Arch Gynecol Obstet. 2024 Jan;309(1):119-126. doi: 10.1007/s00404-022-06751-6. Epub 2022 Aug 22.
5
The role of bacterial translocation in sepsis: a new target for therapy.细菌移位在脓毒症中的作用:一个新的治疗靶点。
Therap Adv Gastroenterol. 2022 May 9;15:17562848221094214. doi: 10.1177/17562848221094214. eCollection 2022.
6
Outstanding Contributions of LAL Technology to Pharmaceutical and Medical Science: Review of Methods, Progress, Challenges, and Future Perspectives in Early Detection and Management of Bacterial Infections and Invasive Fungal Diseases.鲎试剂技术对制药和医学科学的杰出贡献:细菌感染和侵袭性真菌病早期检测与管理的方法、进展、挑战及未来展望综述
Biomedicines. 2021 May 11;9(5):536. doi: 10.3390/biomedicines9050536.
7
High glucose load and endotoxemia among overweight and obese Arab women with and without diabetes: An observational study.患有和未患有糖尿病的超重及肥胖阿拉伯女性中的高糖负荷和内毒素血症:一项观察性研究。
Medicine (Baltimore). 2020 Nov 13;99(46):e23211. doi: 10.1097/MD.0000000000023211.
8
Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.底物结构-活性关系揭示了肠道碱性磷酸酶有限的脂多糖化学型范围。
J Biol Chem. 2019 Dec 13;294(50):19405-19423. doi: 10.1074/jbc.RA119.010836. Epub 2019 Nov 8.
9
Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL6, IL1β, and TNFα levels in type 2 diabetes and insulin resistance.基因 TLR4 和 TLR4 通路成员 TIRAP 和 IRAK1 的常见变异与 2 型糖尿病和胰岛素抵抗患者的 MCP1、IL6、IL1β 和 TNFα 水平相关。
Inflamm Res. 2019 Sep;68(9):801-814. doi: 10.1007/s00011-019-01263-7. Epub 2019 Jun 20.
10
A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements.肠道菌群在肥胖中的作用及益生菌补充剂的抗肥胖特性研究进展
Biomed Res Int. 2019 May 9;2019:3291367. doi: 10.1155/2019/3291367. eCollection 2019.